drugset
drugset / Trial / NCT06143787

Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction

NCT06143787 ↗

Phase 3 Unknown 280 enrolled Hyloris Developments
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the effect of Tranexamic Acid Oral Solution 5% in patients treated with direct oral anticoagulants or vitamin K antagonists and undergoing a single or multiple tooth extraction.

Timeline

Start
2023-11-07
Primary completion
2024-12-27
Completion
2024-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 5 % Oral

Indications

bleeding disorder, vascular-type